Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a pre-defined protocol. We have both interventional & observational types of clinical trials found on this site.
This study offers single fraction radiation treatment through partial breast irradiation in patients with early stage breast cancer after having a lumpectomy.
Elderly cancer patients are a special group, often complicated by a variety of chronic
diseases, which bring serious obstacles to surgery and adjuvant treatment. It is for these
reasons that most patients with high-level evidence-based randomized controlled clinical
trials will be part of these patients. Exclusions ultimately lead to a lack of standards for
the treatment of elderly breast cancer patients, especially the chemotherapy.
Investigators' purpose was to determine whether geriatric assessments are associated with
completion of a chemotherapy course, grade III/IV toxicity or survival in older adults with
breast cancer in older patients.
Investigators want to prospectively enroll breast cancer patients with age ≥70 years. By
recording the pre-treatment baseline laboratory tests and geriatric assessments, through
questionnaires, including Karnofsky performance status(KPS), Eastern Cooperative Oncology
Group(ECOG), Mini Nutritional Assessment(MNA), Activity of daily living(ADL), Instrumental
activities of daily living(IADL), Mini-Mental State Examination(MMSE), Geriatric Depression
Scale(GDS), G-8, Vulnerable Elders Survey-13（VES-13） and FRAIL, Tilburg. Investigators want
to learn the relationship between the geriatric assessments and chemotherapy toxicity,
chemotherapy completion and overall survival. Establish a model for predicting chemotherapy
side effects in old breast cancer patients.
This study will analyze and evaluate the following items:
1. The safety of natural killer（NK） cells for treatment of subjects with solid tumors.
Forty patients will be enrolled for each of the five cancers (in total 200 patients will
be enrolled).
2. The effectiveness of natural killer（NK）cell therapy alone or with chemotherapy or
targeted drugs.
Subjects from 18 to 75 years of age who are diagnosed with a solid tumor including pancreatic
cancer, lung cancer, breast cancer, ovarian cancer and colon cancer, and for whom standard
treatments are not effective, may be eligible for this study. Participants undergo the
following procedures:
Peripheral blood will be collected from a vein of arm. Peripheral blood mononuclear
cells（PBMC） will be isolated and purified for NK manufacturing. After 14~21 days cultivation,
activated NK will be harvested and formulated for clinical administration.
Subjects will receive NK cell treatment by intravenous infusion. The frequency is once every
3 or 4 weeks for the first 3 months. Participants who respond well after 3 months may be
eligible to continue NK cell therapy; and those not may receive NK therapy combined with
chemotherapy and/or targeted drugs, or chemotherapy/targeted drugs alone.
Evaluations during therapy including:
1. Clinical assessment, and history of medications;
2. Blood draws for routine and research tests, including but not limited to: lymphocyte
population and circulating tumor cell analysis in peripheral blood;
3. CT scan, bone scan and positron emission tomography（PET ）scan, if indicated, for disease
evaluation;
4. Pharmacokinetics study after NK infusion. For this test, the number of NK cells in the
blood is measured over time at indicated time-points.